Ofloxacin Ornidazole Tablets combine 200mg Ofloxacin and 500mg Ornidazole to create a powerful antibacterial and antiprotozoal medication. Ofloxacin, a fluoroquinolone antibiotic, works by inhibiting bacterial DNA gyrase and topoisomerase IV enzymes, effectively stopping DNA replication in bacteria. Ornidazole, a nitroimidazole derivative, targets anaerobic bacteria and protozoa by disrupting their DNA structure. This combination ensures broad-spectrum coverage against both aerobic and anaerobic pathogens, making it highly effective for treating mixed infections. The tablets are manufactured under strict quality controls to ensure consistency, safety, and compliance with international pharmaceutical standards. Each batch undergoes rigorous testing for potency, purity, and dissolution to meet healthcare requirements.

This medication is widely used across multiple healthcare settings, including hospitals, clinics, and community health centers. It is particularly valuable in gastroenterology and infectious disease departments for managing diarrhea, dysentery, and abdominal infections caused by susceptible organisms. Pharmaceutical distributors and wholesalers supply these tablets to retail pharmacies, government health programs, and medical missions. The product is also utilized in veterinary medicine for treating similar infections in animals, expanding its application beyond human healthcare. Medical professionals prioritize this combination for its reliability in challenging infection cases where single antibiotics may prove insufficient.

Healthcare providers choosing these tablets benefit from a trusted formulation that reduces treatment time and improves patient outcomes. The product's dual mechanism of action minimizes the risk of resistance development, providing long-term therapeutic value. For suppliers and distributors, the tablets offer competitive pricing and bulk availability to meet specific market needs. The manufacturer's commitment to quality ensures every tablet delivers consistent performance, enhancing your reputation as a reliable provider. With minimal contraindications and a straightforward dosage regimen, this product supports efficient inventory management and high customer satisfaction in competitive healthcare markets.

Key Features:
- Each tablet contains precise doses of Ofloxacin 200mg and Ornidazole 500mg
- Broad-spectrum coverage against bacteria and protozoa
- Manufactured under strict quality control standards
- Consistent dissolution and bioavailability in every batch
- Rigorous testing for potency, purity, and compliance

Benefits:
- Effective treatment for mixed bacterial and protozoal infections
- Reduced risk of antibiotic resistance development
- Trusted formulation with proven therapeutic outcomes
- Competitive pricing and bulk availability for suppliers
- Enhanced patient satisfaction through reliable results